APRICUS BIOSCIENCES, INC. Business Finance Contracts & Agreements

182 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Agreement for Conversion of Convertible Note upon Fundamental Transaction between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2024
Amendment No. 8 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Placement Agent Common Stock Purchase Warrant between Seelos Therapeutics, Inc. and H.C. Wainwright & Co., LLC (July 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (July 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Seelos Therapeutics Inducement Offer to Exercise Warrants Agreement (July 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Amendment No. 7 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (May 21, 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Placement Agency Agreement between Seelos Therapeutics, Inc. and Roth Capital Partners, LLC (May 16, 2024)
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Pre-Funded Common Stock Purchase Warrant between Seelos Therapeutics, Inc. and Holder (May 21, 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Amendment No. 6 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Amendment No. 5 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (January 30, 2024)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (December 1, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (December 1, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2023
Underwriting Agreement between Seelos Therapeutics, Inc. and Titan Partners Group LLC as Representative of the Underwriters
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 4 to Convertible Promissory Note and Letter Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Letter Agreement Amending Convertible Promissory Note Between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (September 2023)
Modification Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (Dated September 25, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 1 to Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers
Modification Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Seelos Therapeutics, Inc. Common Stock Purchase Warrant Agreement (May 19, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 3 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Seelos Therapeutics, Inc. and Holder (March 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Pre-Funded Common Stock Purchase Warrant between Seelos Therapeutics, Inc. and Holder (March 14, 2023)
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 2 to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Open Market Sale Agreement between Seelos Therapeutics, Inc. and Jefferies LLC (May 12, 2022)
Equity Distribution Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Amendment to Convertible Promissory Note between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Seelos Therapeutics, Inc. $22,000,000 Convertible Promissory Note to Lind Global Asset Management V, LLC (Due November 23, 2024)
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement between Seelos Therapeutics, Inc. and Guggenheim Securities, LLC dated May 20, 2021
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers (May 16, 2024)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Description of Securities Registered Pursuant to Section 12 of the Exchange Act – Seelos Therapeutics, Inc.
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2024
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers dated January 26, 2024
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers (September 21, 2023)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Purchasers dated March 10, 2023
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Description of Securities Registered under Section 12 of the Exchange Act – Seelos Therapeutics, Inc.
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2023
Amendment No. 5 to Asset Purchase Agreement between Seelos Corporation and Phoenixus AG (April 8, 2022)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Description of Securities of Seelos Therapeutics, Inc.
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2022
Common Stock Purchase Agreement between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited (November 24, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Security Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (November 23, 2021)
Security Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (November 23, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Amendment No. 4 to Asset Purchase Agreement between Phoenixus AG and Seelos Corporation (February 15, 2021)
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021